Ezose Sciences Inc. announced that it has entered a research agreement with Kyowa Hakko Kirin Co., Ltd. to collaborate on glycomics studies using Ezose's proprietary GlycanMap(R) technology platform. Under terms of the research agreement, Kyowa Hakko Kirin will fund several glycan-biomarker and other discovery projects, with an option for further research and development. Other details of the agreement were not disclosed.